Evaluation of Safety and Efficacy of Supportan® Drink

StatusRecruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Re-verified, no change to tracked fields
  2. Notable Primary and study completion dates: Dec 12, 2025 to Dec 31, 2027 Show 7 more changesShow less
    • Sponsor refiled this as recruiting (was completed)
    • Enrollment target: 123 to 135
    • Interventions: Supportan® Drink, flavour Cappuccino (Dietary Supplement), Supportan® Drink, flavour Pineapple-Coconut (Dietary Supplement), Supportan®… to Supportan® Drink (Dietary Supplement)
    • Eligibility criteria shortened, about 241 words
    • Secondary endpoints shortened, about 151 words
    • Site details revised
    • Study title shortened, about 8 words
  3. Minor 2 versions Re-verified since Apr 24, 2026, no change to tracked fieldsv5-v6
  4. Minor Primary and study completion dates: Dec 26, 2025 to Dec 12, 2025v4
  5. Minor Trial status: Not Yet Recruiting to Completedv3 Show 4 more changesShow less
    • Enrollment target: estimated 135 to confirmed 123
    • Primary completion date changed from estimate of Sep 30, 2025 to Dec 26, 2025
    • Study completion date changed from estimate of Dec 31, 2025 to Dec 26, 2025
    • Start date changed from estimate of Apr 14, 2025 to Apr 8, 2025
  6. Minor Secondary endpoints: 5 to 6
    • Study site revised
    • Study title revised
    v2
  7. Minor Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to demonstrate safety and efficacy of Supportan® Drink
Trial Details
NCT Number NCT06902402
Lead Sponsor Fresenius Kabi Taiwan Ltd.
Conditions
(from sponsor)
Cancer, Malnutrition (Calorie)
Related terms Malnutrition, Neoplasms
Enrollment 135 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov